Stay updated on Ado-Trastuzumab Emtansine in HER2 Amplified Cancers Clinical Trial

Sign up to get notified when there's something new on the Ado-Trastuzumab Emtansine in HER2 Amplified Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ado-Trastuzumab Emtansine in HER2 Amplified Cancers Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.4 in place of v3.6.3, indicating a small update to the page version. This does not modify study details or other user-facing content.
    Difference
    0.1%
    Check dated 2026-07-25T10:27:17.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Revision tag on the page updated from v3.6.2 to v3.6.3, indicating the current page version has been refreshed; the underlying study details remain unchanged.
    Difference
    0.1%
    Check dated 2026-07-03T22:10:53.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The page shows Revision: v3.6.2, replacing the previous Revision: v3.6.0, indicating a minor version update to the page's metadata.
    Difference
    0.1%
    Check dated 2026-06-26T23:24:02.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The page now shows that recruitment is closed for this study, and new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) were added, along with a standardization of the Intervention/Treatment label and a revision footer updated to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T23:39:43.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    An update to the page's revision tag from v3.5.4 to v3.5.5 was applied, indicating a backend/content-management update. This signals a page refresh or republishing rather than changes to the study data or listings.
    Difference
    0.1%
    Check dated 2026-06-05T21:32:21.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    Publications section updated: the older JCO reference with an Erratum is removed, and a newer JCO publication citation related to HER2-mutant cancers is added. This reflects an updated bibliographic record for results associated with the study.
    Difference
    0.1%
    Check dated 2026-05-15T11:41:40.000Z thumbnail image

Stay in the know with updates to Ado-Trastuzumab Emtansine in HER2 Amplified Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ado-Trastuzumab Emtansine in HER2 Amplified Cancers Clinical Trial page.